z-logo
Premium
VII. Are lymphomas driven by epigenetic lesions?
Author(s) -
Boss Isaac W.,
Melnick Ari M.
Publication year - 2015
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2215
Subject(s) - histone code , histone octamer , epigenomics , histone methylation , chromatin , biology , histone methyltransferase , histone , histone h2a , epigenetics , nucleosome , histone modifying enzymes , ezh2 , microbiology and biotechnology , histone h1 , genetics , dna methylation , gene expression , dna , gene
Keywords: B cell; lymphoma; epigenetic regulation; epigenetic modifier mutations; KMT2D; CBP; P300; EZH2; clinical treatment strategies

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom